female Flashcards

1
Q

cervical cancer can spread to the

A

volon and the bladder as there is only a thin endothelial cell in between them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

FSH- NOT ON exam

A

GOES TO THE OVARY -> estrogen-> endometrium -> proliferation of glands (primed for implantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

LH- NOT ON EXAM

A

goes to ovary-> progesterone-> endometrium-> prepares endometrium for implantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hypothalamus release NOT ON EXAM

A

GnRH -> anterior pituitRY -> fsh and LH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Vaginal bleeding

A

hormonal disorder
- dysfunctional uterine bleeding (DUB)

Genital Neoplasia
- fibroids
= endometrial disease
-cervical disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Uterine Fibroids

A

Leiomyoma of Uterus
Benign tumors of smooth muscle cells of myometrium
Almost all benign
Most common uterine tumor (20% of women have them)

Clinical Features:
Small tumors – 	asymptomatic
Larger tumors
“mass effect” (compression of rectum & bladder)
Abdominal heaviness
Constipation
Menstrual irregularities & bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dysfunctional Uterine Bleeding (DUB)

A

Abnormal bleeding in the absence of a well –defined organic lesion in the uterus.
1. Failure of ovulation (anovulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Endometrial Hyperplasia

A

Excess of estrogen (unopposed estrogen) for prolonged periods of time

Causes:
Anovulatory cycles around menopause
Exogenous estrogen
Polycystic ovarian disease( just grows and grows (proliferates

Types:

Simple
Complex
Complex with atypia
Precursor to endometrioid carcinoma (20-25% risk)

need to remove the uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endometrial Carcinoma- if hyperplaisa continues

A

Two Types:
1. Endometrioid Carcinoma:
arises in a background of hyperplasia.
Estrogen dependent

2. Serous carcinoma: 
Estrogen independent. 
Arises in a background of atrophic endometrium.
 P53 mutation. 
High grade

Epidemiology

Age 55-65

Risk Factors:
		Obesity
		Diabetes
		Hypertension
		Infertility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Serous carcinoma:
A
Estrogen independent. 
Arises in a background of atrophic endometrium.
 P53 mutation. 
High grade
usually older in age (70)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. Endometrioid Carcinoma:
A

arises in a background of hyperplasia.
Estrogen dependent
(age 55)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5 stages of cancer growth: Staging

A

– Limited to Mucosa
Stage 1 – Invasive confined to Cx
Stage 2 – Beyond Cx, not reaching pelvic wall
Stage 3 – Reaching Pelvic Wall
Stage 4 – Beyond Pelvis ± Metastases
one it reaches the cervix 50% survival\ once it leaves to bladder-20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Carcinoma of Cervix

A

20% of malignant tumors of female reproductive tract

Mortality reduced by early detection: (Papanicolaou “Pap” Smear)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Etiology and pathogenesis- cervical cancer

A

Human Papillomavirus: (most common) Types 16 and 18

Risk Factors
Sexual Intercourse at Early age
Multiple Sexual Partners
Evidence of HP Virus Infection
Persistent infection by High risk HPV

type of cells: Squamous Cell (lines the vaginal cervic surface)Carcinoma
Originate in Transformation Zone !!!!!(where Endocervix meets Exocervix)(scaumous meets the ___ cells)
Zone of intense cell proliferation (Proliferating cells are susceptible to Viral Infection)
Progresses from low to high grade dysplasia to invasive carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical Features cervicalcancer

A
Median Age 50 years
Age At Dx of CIN 35 years
Early on
Post-coital Bleeding
Vaginal Discharge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most common cause of abnormal uterine/vaginal bleeding is:

A

A. dysfunctional uterine bleeding

17
Q

inflammations

A
Vulvitis
Vaginitis (the first 2- vulvovaginitis)
Cervicitis
Endometritis (PID pelvic inflammatory disease)
Salpingitis
Oophoritis

abnormal implantation, infertility,

18
Q

Pathogenesis of vulvovaginitis

A
Ascending (More Common)
Sexual Contact
Vagina  Uterus  Fallopian Tubes
Descending
Hematogenous or Lymphatic Spread from other organs  (eg Tb)
19
Q

Etiology- vulvovaginitis

A
Protozoa: Trichomonas vaginalis
Chlamydial
Chlamydia trachomatis
Cervicitis
Urethritis
PID
Fungal
Candida albicans(fungal infection) (Monilia)
Vulvovaginitis
20
Q

Common Infections

A

genital herpes and herpes simplex

HPV

Infectious vaginitis - trichomonas, gardnerell, candida

21
Q

Clinical Features

A
All may be associated with systemic symptoms
Fever
Malaise
General Uneasiness
Local Symptoms
Viruses
Blisters or Warts
Vaginitis
Copious discharge
Chlamydia
Vulvitis, Urethritis, Dysuria
Vaginal Discharge
Local Symptoms
Gonorrhea
Urethritis (Dysuria)
Proctitis
PID
Septicemia
Arthritis
22
Q

Pelvic Inflammatory Disease (PID)

A
Salpingitis
Red
Swollen
Filled with Pus
Tubo-ovarian Abscess
Lower Abdominal Pain -> Peritonitis
23
Q

Fibrocystic Change- the duct gets blocked - forms a cyst

A

Consequence of an exaggerated and distortion of the cyclic breast changes that occur normally in the menstrual cycle.
Fibrosis & Cystic Degeneration reactive to Hormonal changes
50% of women show Histologic changes
10 - 15% of women show Clinical Signs

24
Q

sni- etiny??

A

make the milk

25
Q

Pathogenesis

A

Main feature is Fibrosis.
Loose connective tissue replaced by dense collagenous connective tissue unresponsive to hormones.
Breast becomes filled with dense broad sheets of collagenous tissue
Fibrous strands may interrupt blood supply  degenerative changes, necrosis & calcification

26
Q

Pathogenesis

A

Nonproliferative Change:
Ch by increase in fibrous stroma associated with cyst formation.

Proliferative Change:
Nonproliferative + hyperplasia of epithelial cells with in terminal ducts

27
Q

Clinical Features

A
Asymmetrical changes of
Pain
Nodularity
Sensitivity to palpation
Fine Nodularity on palpation
Fluctuating lumps (= cysts)
Difficult to distinguish from malignancy 			  commonly biopsied
28
Q

Fibroadenoma

A

Common benign tumor, young females
2 – 5 cm in diameter
Encapsulated, Round, Lobulated, solitary, discrete, movable
Composed of fibrous stroma & glandular epithelium
May represent exaggerated response of breast tissue to sex hormones, especially estrogen

Most common bening in women
Incidence 1 : 10 women
~ 700 new cases in Sask each year
~ 5,000 deaths in Canada each year

29
Q

Carcinoma of Breast

A

Most common cancer in women
Incidence 1 : 10 women
~ 700 new cases in Sask each year
~ 5,000 deaths in Canada each year

30
Q

Risk Factors

A

Hormonal
increase with prolonged exposure to E2 (estrogen)
(early menarche – late menopause)
Nulliparous women greater risk
Effect of Anti-Estrogen drugs suggests hormonal influence

Premalignant Fibrocystic Changes
Papillomatosis
Atypical Intraductal Hyperplasia
Progress to Invasive Ca over several years

Race
 in Orientals
Common in Caucasians
 in Jews
Reproductive Hx
 Multiparity, Early age pregnancy
 Breast Feeding
31
Q

Pathology

A

Infiltrating Duct Carcinoma
Adenocarcinoma with desmoplastic reaction (dense fibrous tissue response to tumor)
Tumor is firm & gritty
-> retraction of nipple

32
Q

Clinical Features

A

Mass Lesion
80% Detected by Self-examination, Physician palpation, Mammography
Occasionally associated with Enlarged Axillary LN

Detection:
Palpation: 2 – 2.5 cm
Mammography: ~ 0.5 cm
(also look for microcalcification)

33
Q

Diagnosis

A
Fine Needle Aspiration (Cytology)
Surgical Biopsy (Histology)
34
Q

Prognosis

A
Stage I (Localized, <2.5 cm)
80 % 5 year Survival
Stage 2 (2–5 cm  local LN spread)
65 % 5 year Survival
Stage 3 (> 5 cm, No distant mets)
40 % 5 year survival
Stage 4 (Distant Mets) – 10 %
35
Q

Fibroadenoma

A

young pl, 15-35

36
Q

fibrocystic disease

A

35-55

37
Q

carcinoma

A

35- 75